Completed PHASE4 INTERVENTIONAL 2-arm NCT00678574

The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder

Sponsor: National Institute of Mental Health (NIMH)

Conditions Premenstrual Dysphoric Disorder Premenstrual Syndrome

Interventions fluoxetine

Updated 10 times since 2017 Last updated: Jul 25, 2018 Started: Mar 31, 1998 Primary completion: Dec 31, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Premenstrual Dysphoric Disorder and Premenstrual Syndrome, this trial is completed. The trial is conducted by National Institute of Mental Health (NIMH) and has accumulated 10 data snapshots since 1998. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Dec 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 5 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Aug 2018 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Aug 2018 [monthly]

Completed PHASE4
Aug 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Aug 2017 [monthly]

Completed PHASE4

First recorded

Mar 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)
University of Pennsylvania

Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Haven, United States